CNPAX
Price
$74.40
Change
+$0.08 (+0.11%)
Updated
Jun 2 closing price
Net Assets
164.3B
WAGSX
Price
$12.54
Change
-$0.09 (-0.71%)
Updated
Jun 2 closing price
Net Assets
12.57M
Interact to see
Advertisement

CNPAX vs WAGSX

Header iconCNPAX vs WAGSX Comparison
Open Charts CNPAX vs WAGSXBanner chart's image
CNPAX vs WAGSX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. WAGSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and WAGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 164B vs. WAGSX (12.6M). CNPAX pays higher dividends than WAGSX: CNPAX (0.95) vs WAGSX (0.00). CNPAX was incepted earlier than WAGSX: CNPAX (24 years) vs WAGSX (7 years). WAGSX (2.81) is less costly to investors than CNPAX (0.74). WAGSX is a more actively managed with annual turnover of: 43.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than WAGSX: CNPAX (250) vs WAGSX (2000). CNPAX annual gain was more profitable for investors over the last year : 13.85 vs. WAGSX (-2.77). CNPAX return over 5 years is better than : 19.97 vs. WAGSX (-16.52).
CNPAXWAGSXCNPAX / WAGSX
Total Expense Ratio0.741.3654%
Annual Report Gross Expense Ratio0.742.8126%
Fund Existence24 years7 years-
Gain YTD7.2442.850254%
Front Load4%N/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets164B12.6M1,301,587%
Annual Yield % from dividends0.950.00-
Returns for 1 year13.85-2.77-500%
Returns for 3 years44.0520.52215%
Returns for 5 years19.97-16.52-121%
Returns for 10 years123.05N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCPSX44.10N/A
N/A
Communication Services UltraSectorProSvc
CBBYX7.20N/A
N/A
AB Relative Value Advisor
DRISX22.31N/A
N/A
North Square Small Cap Value I
BRWTX30.32N/A
N/A
MFS Blended Research Growth Eq R3
REEIX21.67N/A
N/A
RBC Emerging Markets Equity I